arginine has been researched along with heme arginate in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (20.54) | 18.7374 |
1990's | 30 (26.79) | 18.2507 |
2000's | 32 (28.57) | 29.6817 |
2010's | 24 (21.43) | 24.3611 |
2020's | 3 (2.68) | 2.80 |
Authors | Studies |
---|---|
Kauma, H; Timonen, TT | 1 |
Fitzsimons, E; Houston, T; Jamieson, A; Moore, MR | 1 |
Dover, SB; Fitzsimons, E; Graham, A; McColl, KE; Moore, MR | 1 |
Abraham, NG; Goodman, AI; Levere, RD; Martasek, P; Schwartzman, ML; Solangi, KB | 1 |
Gray, TA; Manning, DJ | 1 |
Goldberg, A; Herrick, AL; McColl, KE; Moore, MR; Wallace, AM | 1 |
Abraham, NG; Escalante, B; Levere, RD; Martasek, P; Schwartzman, ML | 1 |
Lauharanta, J; Mustajoki, P; Tenhunen, R; Timonen, K | 1 |
Abraham, NG; Lin, JH; Martasek, P; Villalon, P | 1 |
Arnold, R; Beckh, K; Blanke, H; Doss, M; Sieg, I; Stellwaag, M | 1 |
Green, D; Ts'ao, CH | 1 |
Kordac, V; Kozáková, M; Martásek, P | 1 |
Cook, A; Goldberg, A; Herrick, AL; McColl, KE; Moore, MR | 1 |
Pierach, CA | 1 |
Juvonen, E; Partanen, S; Ruutu, T; Tenhunen, R | 1 |
Häkli, H; Luhtala, J; Sievers, G; Tenhunen, R | 1 |
Karlsson, M; Lindén, IB; Tenhunen, R; Tokola, O | 1 |
Brodie, MJ; Goldberg, A; Herrick, A; McColl, KE; McLellan, A; Moore, MR | 1 |
Lindén, IB; Tenhunen, R; Tokola, O | 2 |
Volin, L | 1 |
Mustajoki, P; Tenhunen, R; Tokola, O; Volin, L | 2 |
Bakchine, S; Derouesne, C; Fontaine, B; Laplane, D; Nordmann, Y | 1 |
Kordac, V; Martásek, P | 2 |
Cieslar, P; Kordac, V; Kornalík, F; Martásek, P; Spicka, I | 1 |
Himberg, JJ; Mustajoki, P; Tokola, O | 1 |
Rasi, V; Tenhunen, R; Vahtera, E; Volin, L | 1 |
Knuutila, S; Ruutu, T; Tenhunen, R; Volin, L | 1 |
Tokola, O | 2 |
Ruutu, T; Tenhunen, R; Volin, L | 1 |
Tenhunen, R | 1 |
Aderka, D; Dotan, I; Levo, Y; Mamet, R; Schoenfeld, N; Sztern, M | 1 |
Hentze, MW; Pantopoulos, K | 1 |
Deybach, JC; Nordmann, Y; Puy, H | 1 |
Arvela, P; Mustajoki, P; Mustajoki, S; Pelkonen, O; Rautio, A | 1 |
Bharathi, KC; Mamatha, P; Muthane, UB; Vengamma, B | 1 |
Dover, SB; Fitzsimmons, EJ; Graham, A; McColl, KE; Moore, MR | 1 |
Chalevelakis, G; Yalouris, AG | 1 |
Baudry, P; Callebert, J; Deybach, JC; Nordmann, Y; Puy, H; Touitou, Y | 1 |
Mustajoki, P; Nordmann, Y | 1 |
Deybach, JC; Nordmann, Y | 1 |
Kottari, S; Pelkonen, O; Raunio, H; Salonpää, P | 1 |
Battle, A; Fukuda, H; Riley, P; Washbrook, R | 1 |
Mustajoki, P; Tenhunen, R | 1 |
Deybach, JC; Doss, MO; Frank, M; Gross, U; Jacob, K; Nordmann, Y; Sassa, S | 1 |
Ferrini, PR; Santini, V | 1 |
Fibach, E; Friedberg, A; Goldfarb, A; Rachmilewitz, E; Rund, D | 1 |
Karpova, IV; Pivnik, AV; Pustovoĭt, IaS | 1 |
Daimon, M; Hirata, A; Kato, T; Kitagawa, M; Manaka, H; Morita, Y; Sasaki, H; Susa, S | 1 |
Balla, G; Balla, J; Jacob, HS; Jeney, V; Kakuk, G; Vercellotti, GM | 1 |
Doss, MO; Gross, U; Kühnel, A | 1 |
Daimon, M; Igarashi, M; Kameda, W; Kato, T; Susa, S | 1 |
Hoffmann, F; Lindberg, RL; Meyer, UA; Schuurmans, MM | 1 |
Doss, M; Doss, MO; Gross, U; Schurek, JO | 1 |
Elder, GH; Hift, RJ | 1 |
Badminton, MN; Elder, GH | 1 |
Deybach, JC; Doss, M; Doss, MO; Gross, U; Lamoril, J; Meissauer, U; Nordmann, Y; Puy, H | 1 |
Andersson, C; Bäckström, T; Nilsson, A | 1 |
Karpova, IV; Luchinina, IuA; Luk'ianenko, AV; Pivnik, AV; Pustovoĭt, IaS; Surin, VL | 1 |
Hasui, Y; Ikeda, M; Tanabe, H | 1 |
Beer, R; Engelhardt, K; Franz, G; Kampfl, A; Pfausler, B; Schmutzhard, E; Spiegel, M; Trinka, E; Unterberger, I | 1 |
Ishikawa, K; Itabe, H; Kawamura, K; Kimura, S; Kodama, T; Kohro, T; Maruyama, Y; Matsumoto, H; Wada, Y | 1 |
Hift, RJ; Meissner, PN | 1 |
Chen, WJ; Fang, CC; Lai, TI; Lien, WC; Liu, YP; Wang, HP | 1 |
Brand, HS; Kooijman, MM | 1 |
Akagi, R; Maeshima, K; Morita, K; Omori, E; Shimizu, H; Takahashi, T; Tani, T; Uehara, K; Yokoyama, M | 1 |
Kadotani, T; Stevenson, DK; Vreman, HJ; Wong, RJ | 1 |
Frank, J; Merk, HF; Poblete-Gutiérrez, P; Wiederholt, T | 1 |
Badminton, MN; Deybach, JC | 1 |
Bianketti, J; Gregor, A; Lipniacka, A; Szlendak, U | 1 |
Akagi, R; Maeshima, K; Morimatsu, H; Morita, K; Sasaki, T; Shimizu, H; Takahashi, T; Takeuchi, M; Toda, Y; Yokoyama, M | 1 |
Abitbol, M; Deybach, JC; Guénet, JL; Montagutelli, X; Puy, H; Sabaté, JM | 1 |
Feder, ZM; Ignashina, EV; Karpova, IV; Kravchenko, SK; Kremenetskaia, AM; Kurtser, MA; Mironova, TS; Murashko, LE; Petrova, VI; Pustovoĭt, IaS; Pustovoĭt, LA; Shmakov, RG; Shtabnitskiĭ, AM; Sokolova, MIu | 1 |
Borie, MJ; Chauvet, MA; Corcia, P; Diot, E; Maillot, F; Zannad, N | 1 |
Bauer, I; Heiser, J; Kubulus, D; Mathes, A; Pavlidis, D; Pradarutti, S; Raddatz, A; Rensing, H; Wolf, B | 1 |
Andersson, DE; Floderus, Y; Harper, P; Sardh, E | 1 |
Jadhav, A; Ndisang, JF | 4 |
Cappellini, MD; Rocchi, E; Ventura, P | 1 |
Brosche, C; Doss, MO; Koszka, C; Stauch, T; Stölzel, U; Teubner, A | 1 |
Akopova-Larbi, R; Ben Youssef, TI; Gargouri, A; Gouider, R; Gouider-Khouja, N; Kraoua, I | 1 |
Marsden, JT; Rees, DC | 1 |
Andreas, M; Bilban, M; Clive, B; Doberer, D; Haschemi, A; Heinzl, H; Jeitler, M; Wagner, O; Wolzt, M; Zapf, TC | 1 |
Beesley, MF; Choudhary, AK; Clay, S; Conway, BC; Ferenbach, DA; Hughes, J; Kluth, DC; Marson, LP; McKay, J; Nkejabega, NC; Vernon, MA | 1 |
Ma, E; Mar, V; Nicoll, A; Ross, G; Varigos, G | 1 |
Liskova, J; Melkova, Z; Shankaran, P; Vlkova, L | 1 |
Badminton, MN; Barth, JH; Cox, TM; Rees, DC; Sarkany, R; Stein, PE; Stewart, MF | 1 |
Andreas, M; Bilban, M; Doberer, D; Heinze, G; Moser, E; Schewzow, K; Schmid, AI; Weisshaar, S; Wolzt, M | 1 |
Czopek, A; Edmunds, MC; Kluth, DC; Wigmore, SJ | 1 |
Borthwick, G; Cairns, C; Choudhary, AK; Conway, BR; Hughes, J; Kluth, D; Morton, NM; Rennie, J | 1 |
Chibbar, R; Lane, N; Ndisang, JF | 1 |
Albertyn, CH; Bryer, A; Corrigall, A; Heckmann, JM; Meissner, P; Sonderup, M | 1 |
Hnízda, A; Janošík, M; Kopecká, J; Kožich, V; Krijt, J; Melenovská, P; Raková, K; Wilcken, B | 1 |
Chibbar, R; Ndisang, JF | 1 |
Hergüner, Ö; Mungan, NÖ; Nazoglu, S; Öktem, M; Turgut, M; Yildizdas, D; Yilmaz, BS | 1 |
Bilos, A; Dekker, D; Dorresteijn, MJ; Pennings, SW; Peters, WH; Smits, P; Wagener, FA | 1 |
Dosi, R; Joshi, H; Patell, R; Shah, P; Tripathi, R | 1 |
Bellamy, CO; Czopek, A; Kluth, DC; Marson, LP; McNally, SJ; Thomas, RA | 1 |
Deguchi, K; Ikeda, K; Kamada, M; Kokudo, Y; Kume, K; Masaki, T; Takata, T; Touge, T | 1 |
Barman-Aksözen, J; Huber, LC; Minder, E; Senn, JD | 1 |
Andreas, M; Aref, T; Bilban, M; Heidtmann, J; Kainz, FM; Kocher, A; Laufer, G; Messner, B; Oeser, C; Shabanian, S; Wolzt, M | 1 |
Beykirch, MK; Bronisch, O; Haverkamp, T; Petrides, PE; Stauch, T | 1 |
Aarsand, AK; Aguilera, P; Brunet, M; Deulofeu, R; García-Villoria, J; Gómez-Gómez, À; Pozo, OJ; Sandberg, S; To-Figueras, J; Wijngaard, R | 1 |
Beykirch, MK; Klein, M; Loehr, C; Molitor, B; Obermeier, Z; Petrides, PE; Schuhmann, E; Torkler, H | 1 |
Bradberry, SM; Elamin, MEMO; McNally, D; Patel, NC; Stein, P; Wroe, N | 1 |
8 review(s) available for arginine and heme arginate
Article | Year |
---|---|
Hematin: effects on hemostasis.
Topics: Arginine; Blood Coagulation; Heme; Hemin; Hemostasis; Humans; Molecular Structure; Sorbitol | 1990 |
[Hepatic porphyrias and drugs].
Topics: Acute Disease; Alanine; Arginine; Carbohydrates; Heme; Humans; Ligases; Porphyrias, Hepatic | 1994 |
Differentiation therapy of myelodysplastic syndromes: fact or fiction?
Topics: Acetamides; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Azacitidine; Butyrates; Cholecalciferol; Cytarabine; Harringtonines; Hematopoietic Cell Growth Factors; Heme; Homoharringtonine; Humans; Interferons; Myelodysplastic Syndromes; Retinoids | 1998 |
Treatment of acute porphyria.
Topics: Adolescent; Adult; Analgesics, Opioid; Arginine; Clinical Trials as Topic; Dietary Carbohydrates; Female; Heme; Humans; Male; Porphobilinogen; Porphyria, Acute Intermittent; Pregnancy; Pregnancy Complications; Treatment Outcome | 2001 |
Management of acute and cutaneous porphyrias.
Topics: Arginine; beta Carotene; Chloroquine; Estrogens; Ethanol; Heme; Humans; Phlebotomy; Porphyria Cutanea Tarda; Porphyria, Acute Intermittent; Porphyrias; Sunlight | 2002 |
[Porphyria].
Topics: 5-Aminolevulinate Synthetase; Analgesics, Opioid; Antipsychotic Agents; Arginine; Benzodiazepines; Ferrochelatase; Haloperidol; Heme; Humans; Hydroxymethylbilane Synthase; Olanzapine; Pirenzepine; Plasma Exchange; Porphyria, Acute Intermittent; Prognosis | 2003 |
Oral aspects of porphyria.
Topics: Algorithms; Anesthesia, Dental; Arginine; Blister; Carbohydrates; Contraindications; Heme; Humans; Mouth Diseases; Photophobia; Porphobilinogen Synthase; Porphyria, Erythropoietic; Porphyrias, Hepatic; Tooth Discoloration | 2005 |
[CME: Acute Intermittent Porphyria: When to Think of It? What Must be Checked? How to Treat?]
Topics: Arginine; Combined Modality Therapy; Diagnosis, Differential; Female; Genetic Predisposition to Disease; Heme; Hemin; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Middle Aged; Porphobilinogen; Porphyria, Acute Intermittent; Prognosis; Recurrence; Risk Factors | 2018 |
9 trial(s) available for arginine and heme arginate
Article | Year |
---|---|
Haem-arginate plus tin-protoporphyrin for acute hepatic porphyria.
Topics: Adult; Arginine; Female; Heme; Humans; Liver Diseases; Metalloporphyrins; Porphyrias; Prospective Studies; Protoporphyrins | 1991 |
Controlled trial of haem arginate in acute hepatic porphyria.
Topics: Acute Disease; Adolescent; Arginine; Clinical Trials as Topic; Double-Blind Method; Female; Heme; Heroin; Humans; Infusions, Intravenous; Injections, Intravenous; Liver Diseases; Male; Meperidine; Pain; Phlebitis; Porphyrias; Random Allocation; Recurrence; Severity of Illness Index | 1989 |
Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria.
Topics: Acute Disease; Adult; Arginine; Drug Synergism; Drug Therapy, Combination; Female; Heme; Humans; Male; Metalloporphyrins; Porphyrias, Hepatic; Protoporphyrins | 1993 |
Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
Topics: Acute Disease; Adult; Aminolevulinic Acid; Arginine; Biomarkers; Chromatography, Ion Exchange; Drug Monitoring; Female; Glucose; Heme; Humans; Male; Porphobilinogen; Porphyria, Acute Intermittent; Sensitivity and Specificity | 2009 |
Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects.
Topics: Adult; Arginine; Bilirubin; Dose-Response Relationship, Drug; Enzyme Induction; Haptoglobins; Heme; Heme Oxygenase-1; Hemopexin; Homozygote; Humans; Infusions, Intravenous; Male; Polymorphism, Genetic | 2010 |
Heme arginate improves reperfusion patterns after ischemia: a randomized, placebo-controlled trial in healthy male subjects.
Topics: Adolescent; Adult; Arginine; Cross-Over Studies; Follow-Up Studies; Heme; Heme Oxygenase (Decyclizing); Humans; Infusions, Intravenous; Ischemia; Leg; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Oxygen Consumption; Prospective Studies; Reference Values; Reperfusion Injury; Single-Blind Method; Treatment Outcome; Young Adult | 2012 |
Hemin Preconditioning Upregulates Heme Oxygenase-1 in Deceased Donor Renal Transplant Recipients: A Randomized, Controlled, Phase IIB Trial.
Topics: Adult; Aged; Arginine; Biomarkers; Biopsy; Drug Administration Schedule; Enzyme Induction; Female; Heme; Heme Oxygenase-1; Humans; Kidney; Kidney Transplantation; Leukocytes, Mononuclear; Macrophages; Male; Middle Aged; RNA, Messenger; Scotland; Time Factors; Transplant Recipients; Treatment Outcome; Young Adult | 2016 |
Intravenous Heme Arginate Induces HO-1 (Heme Oxygenase-1) in the Human Heart.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Austria; Carboxyhemoglobin; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Induction; Feasibility Studies; Female; Heme; Heme Oxygenase-1; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Middle Aged; Myocardium; RNA, Messenger | 2018 |
Acute porphyrias: a German monocentric study of the biochemical, molecular genetic, and clinical data of 62 families.
Topics: Adult; Anxiety; Arginine; Depression; Family; Female; Germany; Heme; Hospitalization; Humans; Male; Porphyria, Acute Intermittent; Prospective Studies; Quality of Life; Surveys and Questionnaires | 2019 |
95 other study(ies) available for arginine and heme arginate
Article | Year |
---|---|
Therapeutic effect of heme arginate in myelodysplastic syndromes.
Topics: Adult; Aged; Alanine Transaminase; Arginine; Aspartate Aminotransferases; Bone Marrow; Creatinine; Erythropoietin; Female; Heme; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes | 1992 |
Treatment of primary acquired sideroblastic anaemia with haem arginate.
Topics: 5-Aminolevulinate Synthetase; Aged; Aged, 80 and over; Anemia, Sideroblastic; Arginine; Heme; Humans | 1992 |
Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats.
Topics: Animals; Arachidonic Acid; Arginine; Blood Pressure; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Dose-Response Relationship, Drug; Enzyme Induction; Heme; Heme Oxygenase (Decyclizing); Hemin; Hypertension; Kidney; Male; Microsomes, Liver; Mixed Function Oxygenases; Oxygenases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 1991 |
Haem arginate in acute hereditary coproporphyria.
Topics: Arginine; Child; Coproporphyrins; Heme; Humans; Liver Diseases; Male; Porphyrias | 1991 |
Elevation of hormone-binding globulins in acute intermittent porphyria.
Topics: Adolescent; Adult; Aminolevulinic Acid; Arginine; Carrier Proteins; Heme; Humans; Hydrocortisone; Liver Diseases; Porphobilinogen; Porphyrias; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins | 1990 |
Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arginine; Blood Pressure; Blotting, Northern; Cytochrome P-450 Enzyme System; Gene Expression; Heme; Heme Oxygenase (Decyclizing); Hemin; Hypertension; Kidney; Liver; Mixed Function Oxygenases; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; RNA, Messenger | 1990 |
Effects of haem arginate on variegate porphyria.
Topics: Adult; Arginine; Feces; Female; Heme; Humans; Infusions, Intravenous; Photosensitivity Disorders; Porphyrias; Protoporphyrins; Skin; Skin Diseases | 1990 |
Regulation of heme oxygenase gene expression by cobalt in rat liver and kidney.
Topics: Animals; Arginine; Cobalt; DNA; Enzyme Induction; Gene Expression Regulation, Enzymologic; Heme; Heme Oxygenase (Decyclizing); Kidney; Liver; Male; Nucleic Acid Hybridization; Plasmids; Protoporphyrins; Rats; Rats, Inbred Strains; RNA, Messenger; Transcription, Genetic | 1990 |
[The coincidence of acute intermittent porphyria and Crohn's disease].
Topics: Acute Disease; Adult; Arginine; Crohn Disease; Diagnosis, Differential; Drug Therapy, Combination; Glucose; Heme; Humans; Male; Porphyrias; Propranolol; Quadriplegia; Remission Induction | 1990 |
Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration.
Topics: Acute Disease; Adult; Arginine; Cytochrome c Group; Female; Heart; Heme; Humans; Liver Diseases; Male; Middle Aged; Porphyrias | 1989 |
Haem and porphyria attacks.
Topics: Arginine; Drug Evaluation; Heme; Humans; Porphyrias | 1989 |
Effect of haem arginate on colony formation by haematopoietic progenitors in vitro.
Topics: Arginine; Colony-Forming Units Assay; Heme; Humans; Lymphokines; Tissue Inhibitor of Metalloproteinases | 1989 |
Optical and EPR spectroscopy studies on haem arginate, a new compound used for treatment of porphyria.
Topics: Arginine; Electron Spin Resonance Spectroscopy; Heme; Humans; Mathematics; Molecular Weight; Porphyrias | 1987 |
Fate of haem after parenteral administration of haem arginate to rabbits.
Topics: Adrenal Glands; Animals; Arginine; Bile; Carbon Radioisotopes; Erythrocytes; Heme; Injections, Intramuscular; Injections, Intravenous; Iron Radioisotopes; Kinetics; Liver; Rabbits; Tissue Distribution | 1987 |
Effect of haem arginate therapy on porphyrin metabolism and mixed function oxygenase activity in acute hepatic porphyria.
Topics: Acute Disease; Adult; Antipyrine; Arginine; Cytochrome P-450 Enzyme System; Depression, Chemical; Female; Heme; Humans; Hydroxymethylbilane Synthase; Leukocytes; Liver; Liver Diseases; Male; Mitochondria, Liver; Mixed Function Oxygenases; Porphobilinogen Synthase; Porphyrias; Porphyrins | 1987 |
Haem arginate: a new stable haem compound.
Topics: Animals; Arginine; Blood Coagulation; Blood Pressure; Drug Stability; Heme; Heme Oxygenase (Decyclizing); Hydrogen-Ion Concentration; Lethal Dose 50; Mice; Porphyrias; Spectrophotometry, Ultraviolet | 1987 |
Haem arginate treatment for hereditary sideroblastic anaemia.
Topics: Adult; Anemia, Sideroblastic; Arginine; Erythrocyte Count; Erythrocytes; Female; Ferritins; Hematocrit; Heme; Humans; Iron; Transferrin | 1989 |
Heme therapy.
Topics: Arginine; Heme; Humans | 1989 |
[Efficacy and tolerability of a new hematin in the treatment of an acute attack of porphyria].
Topics: Acute Disease; Adolescent; Arginine; Female; Heme; Humans; Porphyrias | 1987 |
Haem arginate in acute hepatic porphyrias.
Topics: Acute Disease; Arginine; Heme; Humans; Liver Diseases; Porphyrias | 1986 |
[The effect of heme arginate (Normosang Leiras--Medica) on hemostasis].
Topics: Arginine; Heme; Hemostasis; Humans; In Vitro Techniques | 1988 |
Haem arginate improves hepatic oxidative metabolism in variegate porphyria.
Topics: Adult; Antipyrine; Arginine; Feces; Female; Heme; Humans; Liver; Oxidation-Reduction; Porphyrias; Porphyrins | 1988 |
Heme arginate: effects on hemostasis.
Topics: Adult; Arginine; Blood; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Female; Heme; Hemostasis; Humans; Male; Osmolar Concentration; Time Factors | 1988 |
Heme arginate treatment for myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Blood Cell Count; Female; Heme; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes | 1988 |
Barbiturate and ethanol sleeping times and pharmacokinetics of propranolol in mice after intravenous administration of haem arginate.
Topics: Animals; Arginine; Ethanol; Heme; Hexobarbital; Injections, Intravenous; Kinetics; Male; Mice; Propranolol; Sleep; Time Factors | 1987 |
Haem arginate as a treatment for myelodysplastic syndromes.
Topics: Adult; Aged; Arginine; Bone Marrow; Female; Heme; Hemoglobins; Humans; Infusions, Intravenous; Leukocyte Count; Male; Myelodysplastic Syndromes; Neutrophils; Platelet Count | 1987 |
Effects of repeated intravenous administration of haem arginate upon hepatic metabolism of foreign compounds in rats and dogs.
Topics: Animals; Arginine; Dogs; Heme; Infusions, Intravenous; Liver; Male; Pharmaceutical Preparations; Rats; Rats, Inbred Strains; Species Specificity | 1987 |
The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats.
Topics: 5-Aminolevulinate Synthetase; Allylisopropylacetamide; Animals; Arginine; Heme; Hemin; Liver; Male; Porphobilinogen; Porphyrias; Rats; Rats, Inbred Strains | 1987 |
[Treatment of acute intermittent porphyria. The first use of Heme-arginate in Czechoslovakia].
Topics: Acute Disease; Adult; Arginine; Heme; Humans; Male; Middle Aged; Porphyrias | 1987 |
[A new drug for porphyria].
Topics: Arginine; Heme; Humans; Porphyrias | 1986 |
Pharmacokinetics of intravenously administered haem arginate.
Topics: Adult; Arginine; Female; Haptoglobins; Heme; Hemopexin; Humans; Injections, Intravenous; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Porphyrias | 1986 |
New treatment for porphyria to be studied.
Topics: Arginine; Female; Heme; Humans; Infusions, Intravenous; Male; Porphyrias | 1995 |
Relation between uroporphyrin excretion, acute attacks of hereditary coproporphyria and successful treatment with haem arginate.
Topics: Acute Disease; Adult; Arginine; Erythrocytes; Heme; Humans; Hydroxymethylbilane Synthase; Male; Porphyrias, Hepatic; Porphyrins; Spectrometry, Fluorescence; Uroporphyrins | 1995 |
Rapid responses to oxidative stress mediated by iron regulatory protein.
Topics: Aconitate Hydratase; Animals; Arginine; Cells, Cultured; Citrates; Citric Acid; Ethers, Cyclic; Ferritins; Fibroblasts; Heme; Hydrogen Peroxide; Iron-Regulatory Proteins; Mice; Okadaic Acid; Oxidative Stress; Phosphoprotein Phosphatases; Receptors, Transferrin; RNA-Binding Proteins; RNA, Messenger | 1995 |
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men.
Topics: Adult; Arginine; Caffeine; Coumarins; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Heme; Humans; Isoenzymes; Lidocaine; Male; Middle Aged; Porphyrias, Hepatic; Reference Values | 1994 |
Porphyric neuropathy: prevention of progression using haeme-arginate.
Topics: Adult; Arginine; Glucose Solution, Hypertonic; Heme; Humans; Male; Peripheral Nervous System Diseases; Porphyria, Acute Intermittent | 1993 |
Haem administration in myelodysplastic syndromes: a possible mechanism of action.
Topics: alpha-Thalassemia; Arginine; beta-Thalassemia; Globins; Heme; Humans; Myelodysplastic Syndromes; Reticulocytes | 1993 |
Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks.
Topics: Adult; Arginine; Circadian Rhythm; Female; Heme; Humans; Melatonin; Porphyria, Acute Intermittent; Recurrence; Tryptophan | 1993 |
Early administration of heme arginate for acute porphyric attacks.
Topics: Adult; Aged; Arginine; Female; Heme; Humans; Length of Stay; Male; Middle Aged; Porphyria, Acute Intermittent; Time Factors; Treatment Outcome | 1993 |
[Acute attacks of hepatic porphyria: specific treatment with heme arginate].
Topics: Acute Disease; Arginine; Female; Heme; Hospitalization; Humans; Infusions, Intravenous; Male; Porphyrias, Hepatic; Time Factors | 1993 |
Regulation of CYP 2 A 5 induction by porphyrinogenic agents in mouse primary hepatocytes.
Topics: Animals; Arginine; Aryl Hydrocarbon Hydroxylases; Cells, Cultured; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Dactinomycin; Enzyme Induction; Griseofulvin; Heme; Liver; Male; Mice; Mice, Inbred DBA; Mixed Function Oxygenases; Nitrobenzoates; Phenobarbital; RNA, Messenger | 1997 |
Stimulation of tetrapyrrole synthesis in mammalian epithelial cells in culture by exposure to aminolaevulinic acid.
Topics: Aminolevulinic Acid; Animals; Arginine; Biological Transport; Carbon Radioisotopes; Cattle; Cell Division; Cell Line; Cycloheximide; Dactinomycin; Epithelium; gamma-Aminobutyric Acid; Glutamic Acid; Heme; Kinetics; Leucine; Mammals; Pyrroles; Radioisotope Dilution Technique; Tetrapyrroles | 1997 |
Acute porphyria: treatment with heme.
Topics: Acute Disease; Arginine; Heme; Hemin; Humans; Porphyrias, Hepatic | 1998 |
5-Aminolevulinic acid dehydratase deficiency porphyria: a twenty-year clinical and biochemical follow-up.
Topics: Adolescent; Aminolevulinic Acid; Arginine; Biomarkers; Erythrocytes; Follow-Up Studies; Glucose; Heme; Humans; Male; Mutation; Porphobilinogen Synthase; Porphyria, Acute Intermittent; Porphyrins | 1998 |
Heme arginate therapy for beta thalassemia: in vitro versus in vivo effects.
Topics: Adult; Arginine; beta-Thalassemia; Cells, Cultured; Female; Heme; Humans; Infusions, Intravenous; Male; Treatment Outcome | 1998 |
[Clinical manifestations and diagnosis of acute porphyria].
Topics: Acute Disease; Adult; Arginine; Critical Care; Diagnosis, Differential; Female; Glucose; Heme; Humans; Infusions, Intravenous; Male; Middle Aged; Porphyrias; Pregnancy; Quality of Life; Respiration, Artificial | 1999 |
Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis.
Topics: Adult; Arginine; Brain; Female; Fluid Therapy; Heme; Humans; Hyponatremia; Myelinolysis, Central Pontine; Necrosis; Porphyria, Acute Intermittent; Saline Solution, Hypertonic; Seizures; Vasospasm, Intracranial | 1999 |
Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants.
Topics: Arginine; Cell Survival; Cells, Cultured; Deuteroporphyrins; Endothelium, Vascular; Ferric Compounds; Ferritins; Gene Expression Regulation; Heme; Heme Oxygenase (Decyclizing); Hemin; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Neutrophils; Oxidation-Reduction; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiobarbituric Acid Reactive Substances; Transcription, Genetic; Umbilical Veins | 2000 |
Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Arginine; Child; Chromatography, High Pressure Liquid; Coproporphyrinogen Oxidase; Coproporphyrins; Feces; Female; Germany; Heme; Heterozygote; Humans; Isomerism; Male; Middle Aged; Porphobilinogen; Porphyrias, Hepatic; Uroporphyrins | 2000 |
Administration of heme arginate, but not hematin, caused anaphylactic shock.
Topics: Adult; Anaphylaxis; Arginine; Female; Heme; Hemin; Humans; Porphyria, Acute Intermittent | 2001 |
Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in a mouse model of acute hepatic porphyria.
Topics: 5-Aminolevulinate Synthetase; Acute Disease; Aminolevulinic Acid; Animals; Arginine; Cytosol; Drug Combinations; Female; Heme; Heme Oxygenase (Decyclizing); Injections, Intraperitoneal; Liver; Metalloporphyrins; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Phenobarbital; Porphyria, Acute Intermittent; Porphyrias, Hepatic; Reference Values; RNA, Messenger | 2001 |
Haem arginate interferes with estimation of carcinoembryonic antigen.
Topics: Adult; alpha-Fetoproteins; Arginine; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Chemistry, Clinical; Erythrocytes; False Positive Reactions; Female; Heme; Hemoglobins; Humans; Porphyrias, Hepatic; Prostate-Specific Antigen | 2001 |
["Acute intermittent porphyria" diagnosis. An odyssey in diagnosis].
Topics: Abdominal Pain; Arginine; Colic; Diagnosis, Differential; Heme; Humans; Porphyria, Acute Intermittent | 2002 |
A molecular, enzymatic and clinical study in a family with hereditary coproporphyria.
Topics: Adult; Aminolevulinic Acid; Arginine; Coproporphyrinogen Oxidase; DNA Mutational Analysis; Feces; Female; Heme; Humans; Porphyrias; Protein Denaturation | 2002 |
Atypical attack of acute intermittent porphyria--paresis but no abdominal pain.
Topics: Abdominal Pain; Adult; Arginine; Disease Progression; Estradiol; Female; Heme; Humans; Hysterectomy; Middle Aged; Ovariectomy; Paresis; Periodicity; Porphyria, Acute Intermittent; Progesterone; Recurrence | 2002 |
[Clinical manifestations of porphyrin metabolism disorders].
Topics: Acute Disease; Adolescent; Adult; Arginine; Chronic Disease; Female; Heme; Humans; Inosine Diphosphate; Middle Aged; Octreotide; Plasmapheresis; Porphyria, Acute Intermittent; Porphyria, Erythropoietic; Porphyrias; Porphyrins | 2003 |
Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option?
Topics: Abortion, Induced; Adult; Arginine; Brain Mapping; Diffusion Magnetic Resonance Imaging; Electroencephalography; Female; Frontal Lobe; Heme; Humans; Porphyrias, Hepatic; Porphyrins; Pregnancy; Status Epilepticus; Time Factors | 2004 |
Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction.
Topics: Animals; Aorta; Aorta, Thoracic; Arginine; Bilirubin; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Gene Expression Profiling; Gene Expression Regulation; Heme; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; In Vitro Techniques; Inflammation; Lipoproteins, LDL; Membrane Proteins; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oligonucleotide Array Sequence Analysis; Tumor Necrosis Factor-alpha; Vasodilation | 2005 |
An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity.
Topics: Abdominal Pain; Acute Disease; Adult; Age Factors; Arginine; Epidemiologic Methods; Female; Heme; Humans; Hypertension; Male; Porphyria, Acute Intermittent; Porphyria, Variegate; Precipitating Factors; Psychotic Disorders; Remission, Spontaneous; Sex Factors; South Africa; Tachycardia | 2005 |
ED presentation of acute porphyria.
Topics: Abdominal Pain; Adolescent; Adult; Age of Onset; Analgesia; Arginine; Diagnostic Errors; Emergency Medicine; Emergency Service, Hospital; Female; Glucose; Heme; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Porphyria, Acute Intermittent; Retrospective Studies; Seizures; Taiwan; Treatment Outcome | 2005 |
Prevention of hemorrhagic shock-induced lung injury by heme arginate treatment in rats.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; Heat-Shock Proteins; Heme; Heme Oxygenase (Decyclizing); Lung; Male; Oxygenases; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Shock, Hemorrhagic; Tumor Necrosis Factor-alpha | 2005 |
Determination of carbon monoxide (CO) in rodent tissue: effect of heme administration and environmental CO exposure.
Topics: Animals; Arginine; Carbon Monoxide; Chromatography, Gas; Environmental Exposure; Heme; Male; Mice; Mice, Inbred BALB C; Rats; Rats, Wistar | 2005 |
[Laboratory tests and therapeutic strategies for the porphyrias].
Topics: Algorithms; Arginine; Critical Care; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Genetic Predisposition to Disease; Heme; Humans; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrias | 2006 |
Treatment of an acute attack of porphyria during pregnancy.
Topics: Abortion, Induced; Arginine; Female; Heme; Humans; Porphyria, Acute Intermittent; Pregnancy; Pregnancy Complications, Infectious | 2006 |
[Acute intermittent porphyria and oral contraception. Case report].
Topics: Adult; Arginine; Contraceptives, Oral, Synthetic; Desogestrel; Female; Glucose; Heme; Humans; Porphyria, Acute Intermittent; Saline Solution, Hypertonic; Treatment Outcome | 2006 |
Heme arginate pretreatment attenuates pulmonary NF-kappaB and AP-1 activation induced by hemorrhagic shock via heme oxygenase-1 induction.
Topics: Animals; Arginine; Electrophoretic Mobility Shift Assay; Enzyme Induction; Heme; Heme Oxygenase (Decyclizing); Lung; Male; NF-kappa B; Rats; Shock, Hemorrhagic; Transcription Factor AP-1 | 2006 |
Ursodesoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model.
Topics: Animals; Arginine; Cholagogues and Choleretics; Disease Models, Animal; Hematopoiesis; Heme; Injections, Intraperitoneal; Liver; Mice; Mice, Transgenic; Protoporphyria, Erythropoietic; Ursodeoxycholic Acid | 2006 |
[Management of pregnancy in women with acute porphyria. Case reports].
Topics: Adult; Arginine; Female; Follow-Up Studies; Heme; Humans; Infant, Newborn; Male; Porphobilinogen; Porphyria, Acute Intermittent; Porphyrins; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Risk Factors | 2007 |
[Favorable outcome of acute porphyric neuropathy after treatment with heme arginate].
Topics: Adult; Arginine; Electrodiagnosis; Electrophysiology; Female; Heme; Humans; Laparoscopy; Motor Neuron Disease; Nervous System Diseases; Neural Conduction; Ovarian Cysts; Peripheral Nerves; Porphyria, Acute Intermittent; Postoperative Complications; Quadriplegia | 2007 |
Hemin arginate-induced heme oxygenase 1 expression improves liver microcirculation and mediates an anti-inflammatory cytokine response after hemorrhagic shock.
Topics: Animals; Anti-Inflammatory Agents; Arginine; Cytokines; Heat-Shock Proteins; Heme; Heme Oxygenase-1; Hemorrhage; Interleukin-10; Liver; Male; Microcirculation; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Tumor Necrosis Factor-alpha | 2008 |
Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension.
Topics: Animals; Arginine; Cardiomegaly; Desoxycorticosterone; Disease Models, Animal; Heart; Heart Diseases; Heme; Heme Oxygenase (Decyclizing); Hypertension; Hypertrophy, Left Ventricular; Male; MAP Kinase Kinase 4; Mesoporphyrins; Myocardium; NF-kappa B; Rats; Rats, Sprague-Dawley; Transcription Factor AP-1; Transforming Growth Factor beta | 2009 |
The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine.
Topics: Arginine; Diagnostic Errors; Emergency Medicine; Heme; Humans; Internal Medicine; Porphyria, Acute Intermittent | 2009 |
Safe and probably safe drugs in acute hepatic porphyria.
Topics: 5-Aminolevulinate Synthetase; Arginine; Drug-Related Side Effects and Adverse Reactions; Heme; Humans; Liver Transplantation; Porphyria, Acute Intermittent | 2009 |
[Neurological complications of acute intermittent porphyria precipitated by porphyrinogenic drugs and efficiency of heme-arginate treatment].
Topics: Acute Disease; Adolescent; Arginine; Electromyography; Famotidine; Female; Heme; Heme Oxygenase (Decyclizing); Humans; Nifedipine; Peripheral Nervous System Diseases; Phenobarbital; Porphyrias; Porphyrinogens; Time Factors | 2009 |
Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats.
Topics: Animals; Arginine; Arterioles; Blood Pressure; Calcium; Cyclic GMP; Desoxycorticosterone; Dinoprost; Endothelin-1; Heme; Heme Oxygenase (Decyclizing); Hypertension; Inositol 1,4,5-Trisphosphate; Intracellular Fluid; Male; Mesenteric Arteries; Mineralocorticoids; NF-kappa B; Organometallic Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Second Messenger Systems; Sodium Chloride, Dietary; Type C Phospholipases; Up-Regulation | 2010 |
Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Topics: Adiponectin; Animals; Arginine; Atrial Natriuretic Factor; Blood Pressure; Blotting, Western; Desoxycorticosterone; Disease Models, Animal; Endothelin-1; Heme; Heme Oxygenase (Decyclizing); Hypertension; Kidney; Kidney Diseases; Male; Mineralocorticoids; Rats; Rats, Sprague-Dawley | 2010 |
A retrospective analysis of outcome of pregnancy in patients with acute porphyria.
Topics: Abortion, Spontaneous; Adolescent; Adult; Arginine; Child; Female; Heme; Humans; Live Birth; London; Middle Aged; Porphyria, Acute Intermittent; Pregnancy; Pregnancy Complications; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2010 |
The induction of macrophage hemeoxygenase-1 is protective during acute kidney injury in aging mice.
Topics: Acute Kidney Injury; Aging; Animals; Arginine; Cells, Cultured; Heme; Heme Oxygenase-1; Kidney; Macrophages; Membrane Proteins; Mice; Reperfusion Injury | 2011 |
Haem arginate as effective maintenance therapy for hereditary coproporphyria.
Topics: Abdominal Pain; Adult; Arginine; Coproporphyria, Hereditary; Female; Heme; Humans; Photosensitivity Disorders; Porphobilinogen; Severity of Illness Index; Treatment Outcome | 2011 |
Heme arginate potentiates latent HIV-1 reactivation while inhibiting the acute infection.
Topics: Acetylcysteine; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Arginine; Cell Line; Heme; Heme Oxygenase-1; HIV-1; Humans; Jurkat Cells; Lectins, C-Type; Metalloporphyrins; Protoporphyrins; Proviruses; Reverse Transcription; Virus Activation; Virus Latency; Virus Replication | 2011 |
Acute intermittent porphyria: fatal complications of treatment.
Topics: Abdominal Pain; Adolescent; Analgesics; Arginine; Disease Management; Fatal Outcome; Female; Hallucinations; Heme; Humans; Hyponatremia; Monitoring, Physiologic; Porphobilinogen; Porphyria, Acute Intermittent; Water-Electrolyte Balance | 2012 |
Treatment with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of Human primary aldosteronism.
Topics: Adiposity; Animals; Arginine; Chemokine CCL2; Disease Models, Animal; Endothelin-1; Enzyme Activators; Gene Expression; Glucose; Heme; Heme Oxygenase (Decyclizing); Humans; Hyperaldosteronism; Insulin; Insulin Resistance; Intercellular Adhesion Molecule-1; Intra-Abdominal Fat; JNK Mitogen-Activated Protein Kinases; Male; Mesoporphyrins; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor AP-1 | 2012 |
Paradoxical effects of heme arginate on survival of myocutaneous flaps.
Topics: Animals; Arginine; Disease Models, Animal; Heme; Heme Oxygenase (Decyclizing); Myocutaneous Flap; Necrosis; Rats; Rats, Inbred Lew; Reperfusion Injury; Skin | 2014 |
Administration of heme arginate ameliorates murine type 2 diabetes independently of heme oxygenase activity.
Topics: 3T3 Cells; Adipocytes; Adipogenesis; Adiponectin; Adipose Tissue; Adiposity; Animals; Arginine; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Heme; Heme Oxygenase (Decyclizing); Hyperglycemia; Inflammation; Insulin-Secreting Cells; Metalloporphyrins; Mice; Pilot Projects | 2013 |
Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension.
Topics: Adiponectin; Aldosterone; Animals; Antioxidants; Arginine; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Chemokine CCL2; Chemokine CCL3; Cyclic GMP; Dinoprost; Endothelin-1; Enzyme Induction; Extracellular Matrix Proteins; Heart Failure; Heme; Heme Oxygenase (Decyclizing); Hypertension; Interleukin-1beta; Interleukin-6; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine | 2014 |
Acute intermittent porphyria presenting as progressive muscular atrophy in a young black man.
Topics: Arginine; Heme; Humans; Hydroxymethylbilane Synthase; Male; Muscular Atrophy, Spinal; Porphyria, Acute Intermittent; Young Adult | 2014 |
Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate.
Topics: Animals; Arginine; Catalytic Domain; CHO Cells; Cricetulus; Cystathionine beta-Synthase; Female; Fibroblasts; Genetic Predisposition to Disease; Heme; Homocystinuria; Homozygote; Humans; Models, Molecular; Molecular Chaperones; Mutation; Phenotype; Protein Conformation; Protein Folding; Proteostasis Deficiencies; Structure-Activity Relationship; Substrate Specificity; Transfection | 2015 |
Heme Oxygenase Improves Renal Function by Potentiating Podocyte-Associated Proteins in Nω-Nitro-l-Arginine-Methyl Ester (l-NAME)-Induced Hypertension.
Topics: Animals; Arginine; Biomarkers; Cytoprotection; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Extracellular Matrix Proteins; Fibrosis; Heme; Heme Oxygenase (Decyclizing); Hypertension; Inflammation Mediators; Kidney; Male; Mesoporphyrins; NG-Nitroarginine Methyl Ester; Oxidative Stress; Podocytes; Rats, Sprague-Dawley; Signal Transduction | 2015 |
A 17-year-old girl with chronic intermittent abdominal pain. Acute intermittent porphyria.
Topics: Abdominal Pain; Adolescent; Arginine; Cholelithiasis; Chronic Disease; Diagnosis, Differential; Female; Heme; Humans; Porphyria, Acute Intermittent; Porphyrins; Tomography, X-Ray Computed | 2015 |
Vascular and metabolic effects of the haem oxygenase-1 inducer haem arginate in subjects with the metabolic syndrome: A translational cross-over study.
Topics: Acetylcholine; Adult; Aged; Arginine; Bilirubin; Cross-Over Studies; Endothelium, Vascular; Female; Ferritins; Glucose Clamp Technique; Heme; Heme Oxygenase-1; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Nitroglycerin; Random Allocation; RNA, Messenger; Translational Research, Biomedical; Vasodilation; Vasodilator Agents | 2016 |
Challenges in the successful management of a case of acute intermittent porphyria in India.
Topics: Abdominal Pain; Administration, Intravenous; Adolescent; Arginine; Heme; Humans; India; Male; Porphobilinogen; Porphyria, Acute Intermittent; Seizures; Treatment Outcome | 2016 |
Acute Intermittent Porphyria Presenting with Posterior Reversible Encephalopathy Syndrome, Accompanied by Prolonged Vasoconstriction.
Topics: Arginine; Female; Heme; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Porphyria, Acute Intermittent; Posterior Leukoencephalopathy Syndrome; Young Adult | 2017 |
Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran.
Topics: Acetylgalactosamine; Adult; Arginine; Cystathionine beta-Synthase; Female; Folic Acid; Heme; Homeostasis; Homocysteine; Homocystinuria; Humans; Hydroxymethylbilane Synthase; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Porphyria, Acute Intermittent; Pyridoxal Phosphate; Pyrrolidines; Young Adult | 2021 |
Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
Topics: 5-Aminolevulinate Synthetase; Acetylgalactosamine; Adult; Arginine; Colitis; Colon, Sigmoid; Controlled Clinical Trials as Topic; Drug Hypersensitivity; Female; Fibrosis; Heme; Hepatocytes; High-Throughput Nucleotide Sequencing; Homocysteine; Humans; Hydroxymethylbilane Synthase; Hyperhomocysteinemia; Male; Models, Biological; Pancreatitis; Porphyria, Acute Intermittent; Pyrrolidines | 2021 |
Safety of haem arginate in overdose: report of an uneventful fourfold accidental overdose.
Topics: Arginine; Drug Overdose; Heme; Humans | 2022 |